Iron trafficking and metabolism in macrophages: Contribution to the polarized phenotype

Trends in Immunology

Volumn 32, Issue 6, 2011, Pages 241-247

  Cairo, Gaetano ^a   Recalcati, Stefania ^a   Mantovani, Alberto ^a,b   Locati, Massimo ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FERROPORTIN; HEME; HEME OXYGENASE; IRON;

GENE EXPRESSION; HUMAN; INFLAMMATION; IRON METABOLISM; IRON TRANSPORT; MACROPHAGE ACTIVATION; NONHUMAN; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TISSUE REPAIR; TUMOR GROWTH;

ANIMALS; BIOLOGICAL TRANSPORT; CELL POLARITY; HUMANS; IRON; MACROPHAGES; PHENOTYPE;

EID: 79957723868     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2011.03.007     Document Type: Review

References (91)

1. Stein M., et al. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J. Exp. Med. 1992, 176:287-292.
2. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
3. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
4. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
5. Martinez F.O., et al. Alternative activation of macrophages: an immunologic functional perspective. Annu. Rev. Immunol. 2009, 27:451-483.
6. Mantovani A., et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002, 23:549-555.
7. Biswas S.K., Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat. Immunol. 2010, 11:889-896.
8. Pollard J.W. Trophic macrophages in development and disease. Nat. Rev. Immunol. 2009, 9:259-270.
9. Martinez F.O., et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
10. Recalcati S., et al. Differential regulation of iron homeostasis during human macrophage polarized activation. Eur. J. Immunol. 2010, 40:824-835.
11. Schaible U.E., Kaufmann S.H. Iron and microbial infection. Nat. Rev. Microbiol. 2004, 2:946-953.
12. Nairz M., et al. The struggle for iron-a metal at the host-pathogen interface. Cell. Microbiol. 2010, 12:1691-1702.
13. Ganz T. Iron in innate immunity: starve the invaders. Curr. Opin. Immunol. 2009, 21:63-67.
14. Nairz M., et al. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur. J. Immunol. 2008, 38:1923-1936.
15. Chlosta S., et al. The iron efflux protein ferroportin regulates the intracellular growth of Salmonella enterica. Infect. Immun. 2006, 74:3065-3067.
16. Nairz M., et al. The co-ordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell. Microbiol. 2007, 9:2126-2140.
17. Paradkar P.N., et al. Iron depletion limits intracellular bacterial growth in macrophages. Blood 2008, 112:866-874.
18. Cellier M.F., et al. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect. 2007, 9:1662-1670.
19. Olakanmi O., et al. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J. Leukoc. Biol. 2007, 81:195-204.
20. Cairo G., et al. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood 1997, 89:2546-2553.
21. Nairz M., et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 2009, 114:3642-3651.
22. Bacci M., et al. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am. J. Pathol. 2009, 175:547-556.
23. Verreck F.A., et al. Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation. J. Leukoc. Biol. 2006, 79:285-293.
24. Corna G., et al. Polarization dictates iron handling by inflammatory and alternatively activated macrophages. Haematologica 2010, 95:1814-1822.
25. Sierra-Filardi E., et al. Heme oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 2010, 215:788-795.
26. Maniecki M.B., et al. CD163 positive subsets of blood dendritic cells: the scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. Immunobiology 2006, 211:407-417.
27. Schaer C.A., et al. Heme carrier protein (HCP-1) spatially interacts with the CD163 hemoglobin uptake pathway and is a target of inflammatory macrophage activation. J. Leukoc. Biol. 2008, 83:325-333.
28. Qiu A., et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 2006, 127:917-928.
29. Zhao R., et al. A role for the proton-coupled folate transporter (PCFT-SLC46A1) in folate receptor-mediated endocytosis. J. Biol. Chem. 2009, 284:4267-4274.
30. Puig-Kroger A., et al. Folate receptor beta is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. 2009, 69:9395-9403.
31. Kato G.J. Haptoglobin halts hemoglobin's havoc. J. Clin. Invest. 2009, 119:2140-2142.
32. Larsen R., et al. A central role for free heme in the pathogenesis of severe sepsis. Sci. Transl. Med. 2010, 2:51ra71.
33. Buehler P.W., et al. Hemoglobin-based oxygen carriers: from mechanisms of toxicity and clearance to rational drug design. Trends Mol. Med. 2010, 16:447-457.
34. Alam J., et al. Nrf2, a Cap'n'Collar transcription factor, regulates induction of the heme oxygenase-1 gene. J. Biol. Chem. 1999, 274:26071-26078.
35. Lee T.S., Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 2002, 8:240-246.
36. Gozzelino R., et al. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 2010, 50:323-354.
37. Motterlini R., Otterbein L.E. The therapeutic potential of carbon monoxide. Nat. Rev. Drug Discov. 2010, 9:728-743.
38. Weis N., et al. Heme oxygenase-1 contributes to an alternative macrophage activation profile induced by apoptotic cell supernatants. Mol. Biol. Cell 2009, 20:1280-1288.
39. Paine A., et al. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem. Pharmacol. 2010, 80:1895-1903.
40. Vallelian F., et al. Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood 2010, 116:5347-5356.
41. Recalcati S., et al. Iron regulatory proteins: from molecular mechanisms to drug development. Antioxid. Redox Signal. 2010, 13:1593-1616.
42. Knutson M.D., et al. Iron loading and erythrophagocytosis increase ferroportin 1 (FPN1) expression in J774 macrophages. Blood 2003, 102:4191-4197.
43. Delaby C., et al. Sequential regulation of ferroportin expression after erythrophagocytosis in murine macrophages: early mRNA induction by haem, followed by iron-dependent protein expression. Biochem. J. 2008, 411:123-131.
44. Marro S., et al. Heme controls ferroportin1 (FPN1) transcription involving Bach1 Nrf2 and a MARE/ARE sequence motif at position -7007 of the FPN1 promoter. Haematologica 2010, 95:1261-1268.
45. Poss K.D., Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10919-10924.
46. Kovtunovych G., et al. Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 2010, 116:6054-6062.
47. Ferris C.D., et al. Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat. Cell Biol. 1999, 1:152-157.
48. Keel S.B., et al. A heme export protein is required for red blood cell differentiation and iron homeostasis. Science 2008, 319:825-828.
49. Seldon M.P., et al. Heme oxygenase-1 inhibits the expression of adhesion molecules associated with endothelial cell activation via inhibition of NF-kappaB RelA phosphorylation at serine 276. J. Immunol. 2007, 179:7840-7851.
50. Wang L., et al. Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice. J. Clin. Invest. 2009, 119:3322-3328.
51. Wang L., et al. Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation. J. Immunol. 2008, 181:2723-2731.
52. Semenza G.L. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci. STKE 2007, 2007:cm8.
53. Takeda N., et al. Differential activation and antagonistic function of HIF-{alpha} isoforms in macrophages are essential for NO homeostasis. Genes Dev. 2010, 24:491-501.
54. Johnson E.E., et al. Role of ferroportin in macrophage-mediated immunity. Infect. Immun. 2010, 78:5099-5106.
55. Weiss G., et al. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 1994, 180:969-976.
56. Melillo G., et al. Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J. Biol. Chem. 1997, 272:12236-12243.
57. Dlaska M., Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 1999, 162:6171-6177.
58. Flierl M.A., et al. Phagocyte-derived catecholamines enhance acute inflammatory injury. Nature 2007, 449:721-725.
59. Flierl M.A., et al. Catecholamines-crafty weapons in the inflammatory arsenal of immune/inflammatory cells or opening pandora's box?. Mol. Med. 2008, 14:195-204.
60. Flierl M.A., et al. Upregulation of phagocyte-derived catecholamines augments the acute inflammatory response. PLoS ONE 2009, 4:e4414.
61. Sandrini S.M., et al. Elucidation of the mechanism by which catecholamine stress hormones liberate iron from the innate immune defense proteins transferrin and lactoferrin. J. Bacteriol. 2010, 192:587-594.
62. Lyte M., et al. Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes. Lancet 2003, 361:130-135.
63. Prasse A., et al. A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am. J. Respir. Crit. Care Med. 2006, 173:781-792.
64. MacMicking J., et al. Nitric oxide and macrophage function. Annu. Rev. Immunol. 1997, 15:323-350.
65. Mora A.L., et al. Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am. J. Respir. Cell Mol. Biol. 2006, 35:466-473.
66. Wagener F.A., et al. The heme-heme oxygenase system: a molecular switch in wound healing. Blood 2003, 102:521-528.
67. Wagener F.A., et al. The heme-heme oxygenase system in wound healing; implications for scar formation. Curr. Drug Targets 2010, 11:1571-1585.
68. Sindrilaru A., et al. An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J. Clin. Invest. 2011, 121:985-997.
69. Pinnix Z.K., et al. Ferroportin and iron regulation in breast cancer progression and prognosis. Sci. Transl. Med. 2010, 2:43ra56.
70. de Sousa M. An outsider's perspective-ecotaxis revisited: an integrative review of cancer environment, iron and immune system cells. Integr. Biol. (Camb.) 2011, 3:343-349.
71. Choi Y.K., et al. Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein. J. Biol. Chem. 2010, 285:32116-32125.
72. Wang X.M., et al. The heme oxygenase-1/carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1. J. Immunol. 2009, 182:3809-3818.
73. Otterbein L.E., et al. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nat. Med. 2000, 6:422-428.
74. Abraham N.G., Drummond G. CD163-Mediated hemoglobin-heme uptake activates macrophage HO-1, providing an antiinflammatory function. Circ. Res. 2006, 99:911-914.
75. Nakahira K., et al. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med. 2006, 203:2377-2389.
76. Pham N.K., et al. Leishmania pifanoi amastigotes avoid macrophage production of superoxide by inducing heme degradation. Infect. Immun. 2005, 73:8322-8333.
77. Mancuso C., et al. Heme oxygenase and cyclooxygenase in the central nervous system: a functional interplay. J. Neurosci. Res. 2006, 84:1385-1391.
78. Mantovani A., et al. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1419-1423.
79. Sullivan J.L. Macrophage iron, hepcidin, and atherosclerotic plaque stability. Exp. Biol. Med. (Maywood) 2007, 232:1014-1020.
80. Orozco L.D., et al. Heme oxygenase-1 expression in macrophages plays a beneficial role in atherosclerosis. Circ. Res. 2007, 100:1703-1711.
81. Skaar E.P., et al. Iron-source preference of Staphylococcus aureus infections. Science 2004, 305:1626-1628.
82. Rodriguez G.M. Control of iron metabolism in Mycobacterium tuberculosis. Trends Microbiol. 2006, 14:320-327.
83. Agranoff D., et al. Mycobacterium tuberculosis expresses a novel pH-dependent divalent cation transporter belonging to the Nramp family. J. Exp. Med. 1999, 190:717-724.
84. Blackwell J.M., et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell. Microbiol. 2001, 3:773-784.
85. Das N.K., et al. Leishmania donovani depletes labile iron pool to exploit iron uptake capacity of macrophage for its intracellular growth. Cell. Microbiol. 2009, 11:83-94.
86. Huynh C., Andrews N.W. Iron acquisition within host cells and the pathogenicity of Leishmania. Cell. Microbiol. 2008, 10:293-300.
87. Andrews S.C., et al. Bacterial iron homeostasis. FEMS Microbiol. Rev. 2003, 27:215-237.
88. Masse E., Arguin M. Ironing out the problem: new mechanisms of iron homeostasis. Trends Biochem. Sci. 2005, 30:462-468.
89. De Domenico I., et al. Hepcidin regulation: ironing out the details. J. Clin. Invest. 2007, 117:1755-1758.
90. Weiss G. Iron metabolism in the anemia of chronic disease. Biochim. Biophys. Acta 2009, 1790:682-693.
91. Kyrou I., Tsigos C. Stress hormones: physiological stress and regulation of metabolism. Curr. Opin. Pharmacol. 2009, 9:787-793.